Literature DB >> 28864426

IL-6-mediated signaling pathways limit Chlamydia muridarum infection and exacerbate its pathogenicity in the mouse genital tract.

Xin Sun1, Qi Tian1, Luying Wang2, Min Xue3, Guangming Zhong4.   

Abstract

Chlamydia muridarum induction of mouse hydrosalpinx, depending on both tubal infection and inflammation, has been used for investigating Chlamydia trachomatis pathogenesis. We now report that IL-6 both inhibits C. muridarum infection and exacerbates pathogenicity in the mouse genital tract. When intravaginally inoculated with a high dose of C. muridarum, IL-6-deficient mice developed more extensive genital tract infection with severe hydrosalpinx, suggesting that IL-6 is required for controlling the high dose infection but not essential for C. muridarum-induced pathology. However, at a low dose, IL-6-deficient mice still developed more extensive infection in the genital tract but no longer with significant pathology, suggesting that IL-6 is required for both controlling the low dose infection and exacerbating the low dose infection-induced pathology. The lack of hydrosalpinx in IL-6-deficient mice correlated with significantly reduced inflammatory infiltration in the oviduct tissue and decreased spleen CD4+ and CD8+ T cells that produce TNFα. Thus, IL-6-dependent pathways are important for both limiting chlamydial colonization in the genital tract mucosal tissues regardless of the infection doses and exacerbating chlamydial pathogenicity in the upper genital tract when IL-6-independent pathogenic mechanisms are not yet activated with a low infection dose.
Copyright © 2017 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Ascending infection; Chlamydia muridarum; Hydrosalpinx; IL-6

Mesh:

Substances:

Year:  2017        PMID: 28864426      PMCID: PMC6034988          DOI: 10.1016/j.micinf.2017.08.007

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  51 in total

1.  Histopathologic changes related to fibrotic oviduct occlusion after genital tract infection of mice with Chlamydia muridarum.

Authors:  Anita A Shah; Justin H Schripsema; Mohammad T Imtiaz; Ira M Sigar; John Kasimos; Peter G Matos; Sandra Inouye; Kyle H Ramsey
Journal:  Sex Transm Dis       Date:  2005-01       Impact factor: 2.830

2.  Vaccination with the Chlamydia trachomatis major outer membrane protein can elicit an immune response as protective as that resulting from inoculation with live bacteria.

Authors:  Sukumar Pal; Ellena M Peterson; Luis M de la Maza
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

Review 3.  Antigen presentation by MHC class II molecules: invariant chain function, protein trafficking, and the molecular basis of diverse determinant capture.

Authors:  F Castellino; G Zhong; R N Germain
Journal:  Hum Immunol       Date:  1997-05       Impact factor: 2.850

4.  Resolution of secondary Chlamydia trachomatis genital tract infection in immune mice with depletion of both CD4+ and CD8+ T cells.

Authors:  S G Morrison; R P Morrison
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

5.  Dissemination of Chlamydia trachomatis chronic genital tract infection in gamma interferon gene knockout mice.

Authors:  T W Cotter; K H Ramsey; G S Miranpuri; C E Poulsen; G I Byrne
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

6.  A role for interleukin-6 in host defense against murine Chlamydia trachomatis infection.

Authors:  D M Williams; B G Grubbs; T Darville; K Kelly; R G Rank
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

7.  Intravaginal inoculation of mice with the Chlamydia trachomatis mouse pneumonitis biovar results in infertility.

Authors:  L M de la Maza; S Pal; A Khamesipour; E M Peterson
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

8.  Protective role of interleukin-6 during Yersinia enterocolitica infection is mediated through the modulation of inflammatory cytokines.

Authors:  Peter H Dube; Scott A Handley; James Lewis; Virginia L Miller
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

9.  Induction of protective immunity against Chlamydia muridarum intravaginal infection with a chlamydial glycogen phosphorylase.

Authors:  Zhihong Li; Chunxue Lu; Bo Peng; Hao Zeng; Zhiguan Zhou; Yimou Wu; Guangming Zhong
Journal:  PLoS One       Date:  2012-03-12       Impact factor: 3.240

10.  Bioluminescence imaging of Chlamydia muridarum ascending infection in mice.

Authors:  Jessica Campbell; Yumeng Huang; Yuanjun Liu; Robert Schenken; Bernard Arulanandam; Guangming Zhong
Journal:  PLoS One       Date:  2014-07-01       Impact factor: 3.240

View more
  13 in total

1.  Gastrointestinal Coinfection Promotes Chlamydial Pathogenicity in the Genital Tract.

Authors:  Qi Tian; Zengzi Zhou; Luying Wang; Al-Mutassim Hani Abu-Khdeir; Zhi Huo; Xin Sun; Nu Zhang; Robert Schenken; Yufeng Wang; Min Xue; Guangming Zhong
Journal:  Infect Immun       Date:  2020-03-23       Impact factor: 3.441

2.  Chlamydial plasmid-encoded virulence factor Pgp3 interacts with human cathelicidin peptide LL-37 to modulate immune response.

Authors:  Shuping Hou; Xin Sun; Xiaohua Dong; Hui Lin; Lingli Tang; Min Xue; Guangming Zhong
Journal:  Microbes Infect       Date:  2018-06-26       Impact factor: 2.700

Review 3.  Chlamydia Spreading from the Genital Tract to the Gastrointestinal Tract - A Two-Hit Hypothesis.

Authors:  Guangming Zhong
Journal:  Trends Microbiol       Date:  2017-12-27       Impact factor: 17.079

4.  Chlamydia muridarum Induces Pathology in the Female Upper Genital Tract via Distinct Mechanisms.

Authors:  Heze Yu; Hui Lin; Lingxiang Xie; Lingli Tang; Jianlin Chen; Zhiguang Zhou; Jiangdong Ni; Guangming Zhong
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

5.  Effects of Immunomodulatory Drug Fingolimod (FTY720) on Chlamydia Dissemination and Pathogenesis.

Authors:  Zengzi Zhou; Lingxiang Xie; Luying Wang; Min Xue; Dabao Xu; Guangming Zhong
Journal:  Infect Immun       Date:  2020-10-19       Impact factor: 3.441

6.  Toll-Like Receptor 3 Deficiency Leads to Altered Immune Responses to Chlamydia trachomatis Infection in Human Oviduct Epithelial Cells.

Authors:  Jerry Z Xu; Ramesh Kumar; Haoli Gong; Luyao Liu; Nicole Ramos-Solis; Yujing Li; Wilbert A Derbigny
Journal:  Infect Immun       Date:  2019-09-19       Impact factor: 3.441

7.  Chlamydia Spreads to the Large Intestine Lumen via Multiple Pathways.

Authors:  Zengzi Zhou; Qi Tian; Luying Wang; Min Xue; Dabao Xu; Guangming Zhong
Journal:  Infect Immun       Date:  2021-07-19       Impact factor: 3.441

Review 8.  Immunopathogenesis of genital Chlamydia infection: insights from mouse models.

Authors:  Jacob Dockterman; Jörn Coers
Journal:  Pathog Dis       Date:  2021-03-31       Impact factor: 3.951

9.  Toll-like receptor 3 (TLR3) promotes the resolution of Chlamydia muridarum genital tract infection in congenic C57BL/6N mice.

Authors:  Sebastian E Carrasco; Sishun Hu; Denise M Imai; Ramesh Kumar; George E Sandusky; X Frank Yang; Wilbert A Derbigny
Journal:  PLoS One       Date:  2018-04-06       Impact factor: 3.240

Review 10.  Insights Into Host Cell Cytokines in Chlamydia Infection.

Authors:  Wenjing Xiang; Nanyan Yu; Aihua Lei; Xiaofang Li; Shui Tan; Lijun Huang; Zhou Zhou
Journal:  Front Immunol       Date:  2021-05-21       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.